![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|20|26|4284-4298
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.20, Iss.26, 2014-08, pp. : 4284-4298
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuroprotective agents in traumatic brain injury
By Maas A.I.
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology, Vol. 7, Iss. 3, 2009-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oxidative Stress in Traumatic Brain Injury
Current Medicinal Chemistry, Vol. 21, Iss. 10, 2014-04 ,pp. :